183 results on '"Conte, Mr"'
Search Results
2. P392Prediction of percutaneous aortic valve size by transthoracic and transesophageal two-dimensional echocardiography
- Author
-
Pizzuti, A, Mabritto, B, Derosa, C, Tomasello, A, Rovere, ME, Parrini, I, and Conte, MR
- Published
- 2011
3. Increased stimulation threshold in a patient with autoimmune disease: successful management with oral prednisolone and azathioprine
- Author
-
Ferraro, A, Masi, A Sibona, Mazza, A, Brusin, MC Rosa, and Conte, MR
- Published
- 2009
4. P440Strain imaging with cardiac magnetic resonance in hypertrophic cardiomyopathy
- Author
-
A Milan, S Seitun, C Lario, G Negro, Massimo Petracchini, A Macera, M Bianco, S Cirillo, C Arese, M De Benedictis, A. Balbo-Mussetto, Conte Mr, Barbara Mabritto, and Alessandro Fornari
- Subjects
medicine.medical_specialty ,business.industry ,Internal medicine ,medicine ,Hypertrophic cardiomyopathy ,Cardiology ,Radiology, Nuclear Medicine and imaging ,General Medicine ,Cardiology and Cardiovascular Medicine ,medicine.disease ,Cardiac magnetic resonance ,business - Published
- 2019
- Full Text
- View/download PDF
5. 15-deoxy-Δ12,14-Prostaglandin J2 inhibits human soluble epoxide hydrolase by a dual orthosteric and allosteric mechanism
- Author
-
Abis, G, Charles, RL, Kopec, J, Yue, WW, Atkinson, RA, Bui, TTT, Lynham, S, Popova, S, Sun, Y-B, Fraternali, F, Eaton, P, Conte, MR, King‘s College London, and University of Oxford [Oxford]
- Subjects
[SDV.BBM.BP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biophysics ,lcsh:Biology (General) ,lcsh:QH301-705.5 ,[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biomolecules [q-bio.BM] - Abstract
Human soluble epoxide hydrolase (hsEH) is an enzyme responsible for the inactivation of bioactive epoxy fatty acids, and its inhibition is emerging as a promising therapeutical strategy to target hypertension, cardiovascular disease, pain and insulin sensitivity. Here, we uncover the molecular bases of hsEH inhibition mediated by the endogenous 15-deoxy-Δ 12,14-Prostaglandin J 2 (15d-PGJ 2). Our data reveal a dual inhibitory mechanism, whereby hsEH can be inhibited by reversible docking of 15d-PGJ 2 in the catalytic pocket, as well as by covalent locking of the same compound onto cysteine residues C423 and C522, remote to the active site. Biophysical characterisations allied with in silico investigations indicate that the covalent modification of the reactive cysteines may be part of a hitherto undiscovered allosteric regulatory mechanism of the enzyme. This study provides insights into the molecular modes of inhibition of hsEH epoxy-hydrolytic activity and paves the way for the development of new allosteric inhibitors.
- Published
- 2019
- Full Text
- View/download PDF
6. PO406 ECG Screening In a Student Population: An Interdisciplinary Project
- Author
-
Conte Mr, M. Segre, A. Sibona Masi, Stefano Grossi, C. De Rosa, and Francesca Bianchi
- Subjects
Community and Home Care ,Medical education ,Student population ,Epidemiology ,business.industry ,Medicine ,Cardiology and Cardiovascular Medicine ,business - Published
- 2018
- Full Text
- View/download PDF
7. [ANMCO/SICI-GISE document on antiplatelet therapy in patients with acute coronary syndrome]
- Author
-
De Luca, Leonardo, Bolognese, Leonardo, Valgimigli, Marco, Ceravolo, Roberto, Danzi, Gian Battista, Piccaluga, Emanuela, Rakar, Serena, Cremonesi, Alberto, Bovenzi, Francesco Maria, Abbate, R, Andreotti, F, Bolognese, L, Biondi Zoccai, G, Bovenzi, FM, Capodanno, D, Caporale, R, Capranzano, P, Carrabba, N, Casella, G, Cavallini, C, Ceravolo, R, Colombo, P, Conte, MR, Cordone, S, Cremonesi, A, Danzi, GB, Del Pinto, M, De Luca, G, De Luca, L, De Servi, S, Di Lorenzo, E, Di Pasquale, G, Farina, R, Fiscella, A, Formigli, D, Galli, S, Giudice, P, Gonzi, G, Greco, C, Grieco, NB, La Vecchia, L, Lazzari, M, Lettieri, C, Lettino, M, Limbruno, U, Lupi, A, Macchi, A, Marini, M, Marzilli, M, Montinaro, A, Musumeci, G, Navazio, A, Olivari, Z, Oltrona Visconti, L, Oreglia, JA, Ottani, F, Parodi, G, Pasquetto, G, Patti, G, Perkan, A, Perna, GP, Piccaluga, E, Piscione, F, Prati, F, Rakar, S, Ravasio, R, Ronco, F, Rossini, R, Rubboli, A, Saia, F, Sardella, G, Satullo, G, Savonitto, S, Sbarzaglia, P, Scorcu, G, Signore, N, Tarantini, G, Terrosu, P, Testa, L, Tubaro, M, Valente, S, Valgimigli, M, Varbella, F, Vatrano, M., ESPOSITO, GIOVANNI, De Luca, Leonardo, Bolognese, Leonardo, Valgimigli, Marco, Ceravolo, Roberto, Danzi, Gian Battista, Piccaluga, Emanuela, Rakar, Serena, Cremonesi, Alberto, Bovenzi, Francesco Maria, Abbate, R, Andreotti, F, Bolognese, L, Biondi Zoccai, G, Bovenzi, Fm, Capodanno, D, Caporale, R, Capranzano, P, Carrabba, N, Casella, G, Cavallini, C, Ceravolo, R, Colombo, P, Conte, Mr, Cordone, S, Cremonesi, A, Danzi, Gb, Del Pinto, M, De Luca, G, De Luca, L, De Servi, S, Di Lorenzo, E, Di Pasquale, G, Esposito, Giovanni, Farina, R, Fiscella, A, Formigli, D, Galli, S, Giudice, P, Gonzi, G, Greco, C, Grieco, Nb, La Vecchia, L, Lazzari, M, Lettieri, C, Lettino, M, Limbruno, U, Lupi, A, Macchi, A, Marini, M, Marzilli, M, Montinaro, A, Musumeci, G, Navazio, A, Olivari, Z, Oltrona Visconti, L, Oreglia, Ja, Ottani, F, Parodi, G, Pasquetto, G, Patti, G, Perkan, A, Perna, Gp, Piccaluga, E, Piscione, F, Prati, F, Rakar, S, Ravasio, R, Ronco, F, Rossini, R, Rubboli, A, Saia, F, Sardella, G, Satullo, G, Savonitto, S, Sbarzaglia, P, Scorcu, G, Signore, N, Tarantini, G, Terrosu, P, Testa, L, Tubaro, M, Valente, S, Valgimigli, M, Varbella, F, and Vatrano, M.
- Subjects
Acute Coronary Syndrome ,Platelet Aggregation Inhibitors ,Human - Abstract
Antiplatelet therapy is the cornerstone of the pharmacologic management of patients with acute coronary syndrome (ACS). Over the last years, several studies have evaluated old and new oral or intravenous antiplatelet agents in ACS patients. In particular, research was focused on assessing superiority of two novel platelet ADP P2Y12 receptor antagonists (i.e., prasugrel and ticagrelor) over clopidogrel. Several large randomized controlled trials have been undertaken in this setting and a wide variety of prespecified and post-hoc analyses are available that evaluated the potential benefits of novel antiplatelet therapies in different subsets of patients with ACS. The aim of this document is to review recent data on the use of current antiplatelet agents for in-hospital treatment of ACS patients. For each drug or class of drugs, strong evidence and/or areas of uncertainty that warrant further research are highlighted by examining 10 subgroups of patients with ACS.
- Published
- 2013
8. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy)
- Author
-
NISTRI S, OLIVOTTO I, VALSECCHI G, PINAMONTI B, CONTE MR, CASAZZA F, MARON BJ, CECCHI F, ON BEHALF PARTICIPATING CENTERS, BETOCCHI, SANDRO, LOSI, MARIA ANGELA, GALDERISI, MAURIZIO, Nistri, S, Olivotto, I, Betocchi, Sandro, Losi, MARIA ANGELA, Valsecchi, G, Pinamonti, B, Conte, Mr, Casazza, F, Galderisi, Maurizio, Maron, Bj, Cecchi, F, and ON BEHALF PARTICIPATING, Centers
- Subjects
Adult ,Male ,medicine.medical_specialty ,Heart disease ,Cardiomyopathy ,Severity of Illness Index ,Sudden death ,Ventricular Outflow Obstruction ,Cohort Studies ,Sex Factors ,Predictive Value of Tests ,Internal medicine ,Atrial Fibrillation ,medicine ,Humans ,Heart Atria ,Registries ,Ultrasonography ,Heart Failure ,business.industry ,Age Factors ,Hypertrophic cardiomyopathy ,Atrial fibrillation ,Cardiomyopathy, Hypertrophic ,Middle Aged ,Prognosis ,medicine.disease ,Italy ,Predictive value of tests ,Heart failure ,Multivariate Analysis ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Biomarkers ,Follow-Up Studies ,Cohort study - Abstract
This study assessed left atrial (LA) dimension as a potential predictor of outcome in hypertrophic cardiomyopathy (HC). From the Italian Registry for Hypertrophic Cardiomyopathy, 1,491 patients (mean age 47 +/- 17 years; 61% men; 19% obstructive), followed for 9.4 +/- 7.4 years after the initial echocardiographic evaluation, constituted the study group. The mean LA transverse dimension was 43 +/- 9 mm and was larger in patients with severe symptoms (48 +/- 9 mm for New York Heart Association classes III and IV vs 42 +/- 9 mm for classes I and II, p0.001), atrial fibrillation (47 +/- 9 vs 42 +/- 8 mm in sinus rhythm, p0.001), and left ventricular outflow obstruction (46 +/- 9 mm foror=30 mm Hg at rest vs 42 +/- 9 mm for30 mm Hg at rest, p0.001). On univariate analysis, each 5-mm increase in LA size was associated with a hazard ratio (HR) of 1.2 for all-cause mortality (p0.0001). On multivariate analysis, a LA dimension48 mm (the 75th percentile) had a HR of 1.9 for all-cause mortality (p = 0.008), 2.0 for cardiovascular death (p = 0.014), and 3.1 for death related to heart failure (p = 0.008) but was unassociated with sudden death (p = 0.81). Similar results were obtained after the exclusion of patients with atrial fibrillation (HR 1.7, p = 0.008) or outflow obstruction (HR 1.8, p = 0.003). The predictive power of LA dimension48 mm was also validated in an independent HC cohort from the United States, with similar HRs (1.8 for all-cause mortality, p = 0.019). In conclusion, in a large cohort of patients with HC from a nationwide registry, a marked increase in LA dimension were predictive of long-term outcome, independent of co-existent atrial fibrillation or outflow obstruction. LA dimension is a novel and independent marker of prognosis in HC, particularly relevant to the identification of patients at risk for death related to heart failure.
- Published
- 2006
9. [Heart failure in Italian intensive cardiac care units: data from the BLITZ-3 survey]
- Author
-
Chinaglia, A, Casella, G, Scorcu, G, Cassin, M, Chiarella, F, Conte, Mr, Fradella, G, Lucci, D, Maggioni, Ap, Visconti, Lo, Autore, Camillo, and Ricercatori dello Studio BLITZ, 3
- Subjects
Heart Failure ,Male ,Intensive Care Units ,Italy ,Data Collection ,Humans ,Female ,Prospective Studies ,Registries ,Aged - Abstract
Only limited information about clinical characteristics, diagnostic procedures and therapeutic options is available in patients admitted to an intensive cardiac care unit (ICCU) for heart failure. The aim of this study was to evaluate causes of admission, clinical characteristics, diagnostic and therapeutic options, and outcome of patients admitted for heart failure in the ICCU network.The BLITZ-3 Registry prospectively included patients admitted by 332 Italian ICCUs. Data of the patients admitted with a principal diagnosis of heart failure are analyzed.From April 7 to 20, 2008, 6986 consecutive patients with acute cardiac conditions were admitted to ICCUs; 966 (14%) out of 6986 patients were admitted for acute heart failure. Heart failure was the second cause of admission after acute coronary syndromes (52%). Mean age of patients admitted for heart failure was 73 years, 42% were female, and diabetes accounted for 32% of heart failure patients. Most patients were admitted to the emergency department (62%), and were discharged by the cardiology ward (65%). Median length of stay in the ICCU was 4 days, and during the stay in ICCU 5% of the patients with heart failure died. Advanced age and elevated creatinine values were associated with a higher risk of death. Echocardiography was performed in 79% of heart failure patients, coronary angiography in 10%, assisted ventilation in 15%, ultrafiltration in 3%, and right catheterization in 1%. Diuretics were administered in 93% of patients admitted for acute heart failure, intravenous nitrates in 41%, inotropes in 22%, beta-blockers in 42%, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in 66%.In a nationwide survey, acute heart failure accounted for 14% of hospital admissions in ICCUs. Patients admitted for heart failure are usually old, with frequent comorbidities. Diagnostic and therapeutic procedures are rarely used, with the exception of echocardiography.
- Published
- 2012
10. Primary percutaneous coronary intervention without on-site cardiac surgery backup in unselected patients with ST-segment-elevation myocardial infarction: the Rivoli ST-segment elevation myocardial infarction (RISTEMI) registry
- Author
-
Tomassini, F, Gagnor, A, Montali, N, Infantino, V, Tizzani, E, Tizzani, P, Lanza, Gaetano Antonio, Conte, Mr, Varbella, F., Lanza, Gaetano Antonio (ORCID:0000-0003-2187-6653), Tomassini, F, Gagnor, A, Montali, N, Infantino, V, Tizzani, E, Tizzani, P, Lanza, Gaetano Antonio, Conte, Mr, Varbella, F., and Lanza, Gaetano Antonio (ORCID:0000-0003-2187-6653)
- Abstract
Primary percutaneous coronary intervention (PCI) is the preferred reperfusion strategy for patients with ST-segment-elevation myocardial infarction (STEMI), but some concerns remain about its safety and efficacy in centers without on-site cardiac surgery (OCS).
- Published
- 2013
11. Heterodimerization of the human RNase P/MRP subunits Rpp20 and Rpp25 is a prerequisite for interaction with the P3 arm of RNase MRP RNA
- Author
-
Hands-Taylor, KLD, Martino, L, Tata, R, Babon, JJ, Bui, TT, Drake, AF, Beavil, RL, Pruijn, GJM, Brown, PR, Conte, MR, Hands-Taylor, KLD, Martino, L, Tata, R, Babon, JJ, Bui, TT, Drake, AF, Beavil, RL, Pruijn, GJM, Brown, PR, and Conte, MR
- Abstract
Rpp20 and Rpp25 are two key subunits of the human endoribonucleases RNase P and MRP. Formation of an Rpp20-Rpp25 complex is critical for enzyme function and sub-cellular localization. We present the first detailed in vitro analysis of their conformational properties, and a biochemical and biophysical characterization of their mutual interaction and RNA recognition. This study specifically examines the role of the Rpp20/Rpp25 association in the formation of the ribonucleoprotein complex. The interaction of the individual subunits with the P3 arm of the RNase MRP RNA is revealed to be negligible whereas the 1:1 Rpp20:Rpp25 complex binds to the same target with an affinity of the order of nM. These results unambiguously demonstrate that Rpp20 and Rpp25 interact with the P3 RNA as a heterodimer, which is formed prior to RNA binding. This creates a platform for the design of future experiments aimed at a better understanding of the function and organization of RNase P and MRP. Finally, analyses of interactions with deletion mutant proteins constructed with successively shorter N- and C-terminal sequences indicate that the Alba-type core domain of both Rpp20 and Rpp25 contains most of the determinants for mutual association and P3 RNA recognition.
- Published
- 2010
12. An ARG403GLN beta-myosin heavy chain gene mutation identified in an Italian family with hypertrophic cardiomyopathy; description of clinical features of the family members
- Author
-
L. Checco, Conte Mr, G. Bonfiglio, Fulvio Orzan, A. Alfarano, Mangiardi L, C. Camaschella, Brusca A, and M. Morello
- Subjects
Genetics ,Adult ,Male ,Myosin Heavy Chains ,business.industry ,Genetic Linkage ,Hypertrophic cardiomyopathy ,DNA ,Gene mutation ,Cardiomyopathy, Hypertrophic ,Middle Aged ,medicine.disease ,Pedigree ,Electrocardiography ,Italy ,Echocardiography ,Child, Preschool ,Myosin ,Mutation ,Medicine ,Humans ,Female ,Cardiology and Cardiovascular Medicine ,business ,Child - Published
- 1997
13. Severe coronary artery disease after radiation therapy of the chest and mediastinum: clinical presentation and treatment
- Author
-
Fulvio Orzan, Brusca A, M C Figliomeni, Conte Mr, and Patrizia Presbitero
- Subjects
Thorax ,Adult ,Male ,medicine.medical_specialty ,Lymphoma ,Infarction ,Breast Neoplasms ,Coronary Disease ,Mediastinal Neoplasms ,Angina ,Coronary artery disease ,Internal medicine ,medicine ,Humans ,Myocardial infarction ,Retrospective Studies ,medicine.diagnostic_test ,Radiotherapy ,business.industry ,Mediastinum ,Retrospective cohort study ,Dose-Response Relationship, Radiation ,Sarcoma ,Middle Aged ,Thoracic Neoplasms ,medicine.disease ,Hodgkin Disease ,medicine.anatomical_structure ,Angiography ,Cardiology ,Female ,Radiology ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies ,Research Article - Abstract
OBJECTIVE--To define the clinical and angiographic features and the therapeutic problems in patients with coronary artery disease after therapeutic irradiation of the chest. DESIGN--An observational retrospective study. SETTING--The cardiac catheterisation laboratory, university medical school. PATIENTS--15 subjects (8 men and 7 women, aged 25-56 years, mean 44) examined in the cardiac catheterisation laboratory, who had significant coronary artery disease years after having radiation treatment to the chest and anterior mediastinum. In the early stages of the study angiography was performed because of typical symptoms of ischaemic heart disease. Later on it was performed because of a high index of suspicion in people with signs of extensive radiation heart damage. MAIN OUTCOME MEASURES--Clinical and electrocardiographic evidence of ischaemic heart disease; echocardiographic signs of pericardial, myocardial or valvar involvement; angiographic evidence of coronary arterial stenosis, with special attention to the ostia; haemodynamic and angiographic signs of pericardial, myocardial, and valvar disease. Survival and symptomatic and functional status were ascertained after medical or surgical treatment. RESULTS--The patients were relatively young and had no risk factors. Seven patients had no signs or symptoms of ischaemic heart disease. Ten patients had ostial stenosis, which was associated with extensive involvement of other cardiac structures in nine of them. Seven required surgical treatment for coronary artery disease. Two died, one at surgery and the other one six months later. Five patients had complications associated with irradiation. CONCLUSIONS--Coronary arterial disease can be reasonably ascribed to the effects of chest irradiation when the patients are young and free from risk factors, especially if the obstructions are ostial and there is important damage to other cardiac structures. In patients with damage to other cardiac structures angina and infarction are often absent and coronary angiography seems to be mandatory. Patients often require surgical treatment and postoperative complications are common.
- Published
- 1993
14. Syncope and risk of sudden death in hypertrophic cardiomyopathy.
- Author
-
Spirito P, Autore C, Rapezzi C, Bernabò P, Badagliacca R, Maron MS, Bongioanni S, Coccolo F, Estes NA, Barillà CS, Biagini E, Quarta G, Conte MR, Bruzzi P, and Maron BJ
- Published
- 2009
- Full Text
- View/download PDF
15. Risk associated with pregnancy in hypertrophic cardiomyopathy.
- Author
-
Autore C, Conte MR, Piccininno M, Bernabò P, Bonfiglio G, Bruzzi P, Spirito P, Autore, Camillo, Conte, Maria Rosa, Piccininno, Marco, Bernabò, Paola, Bonfiglio, Giovanna, Bruzzi, Paolo, and Spirito, Paolo
- Abstract
Objectives: We sought to assess mortality and morbidity in pregnant women with hypertrophic cardiomyopathy (HCM).Background: The risk associated with pregnancy in women with HCM is an important and increasingly frequent clinical issue for which systematic data are not available and a large measure of uncertainty persists.Methods: Maternal mortality in 91 consecutively evaluated families with HCM was compared with that reported in the general population. The study cohort included 100 women with HCM with one or more live births, for a total of 199 live births. Morbidity related to HCM during pregnancy was investigated in 40 women evaluated within five years of their pregnancy.Results: Two pregnancy-related deaths occurred, both in patients at a particularly high risk. The maternal mortality rate was 10 per 1,000 live births (95% confidence interval [CI] 1.1 to 36.2/1,000) and was in excess of the expected mortality in the general Italian population (relative risk 17.1, 95% CI 2.0 to 61.8). In the 40 patients evaluated within close proximity of their pregnancy, 1 (4%) of the 28 who were previously asymptomatic and 5 (42%) of the 12 with symptoms progressed to functional class III or IV during pregnancy (p < 0.01). One patient had atrial fibrillation and one had syncope, both of whom had already experienced similar and recurrent events before their pregnancy.Conclusions: Maternal mortality is increased in patients with HCM compared with the general population. However, absolute maternal mortality is low and appears to be principally confined to women at a particularly high risk. In the presence of a favorable clinical profile, the progression of symptoms, atrial fibrillation, and syncope are also uncommon during pregnancy. [ABSTRACT FROM AUTHOR]- Published
- 2002
- Full Text
- View/download PDF
16. Atypical chest pain: coronary or esophageal disease?
- Author
-
Conte Mr, L. Todros, Fulvio Orzan, P.R. Mioli, P. Zara, Brusca A, and M. Magnacca
- Subjects
Adult ,Male ,Thorax ,Chest Pain ,medicine.medical_specialty ,Arterial disease ,Disease ,Esophageal Diseases ,Angina Pectoris ,Diagnosis, Differential ,Angina ,Very frequent ,Internal medicine ,medicine ,Humans ,In patient ,Aged ,Esophageal disease ,business.industry ,Atypical chest pain ,Middle Aged ,medicine.disease ,Gastroesophageal Reflux ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business - Abstract
Retrosternal pain can be caused both by cardiac and esophageal disease. This work presents the results of cardiac and esophageal investigations in 55 patients, who had atypical chest pain. Isolated esophageal disease was found in 45% of the subjects while 14.5% had significant coronary arterial disease. Both diseases were found in 10.9% of the patients and neither disease in 29%. We conclude that esophageal disease is very frequent in patients with atypical chest pain but it does not always completely account for the symptoms. Such patients should, in our opinion, be submitted to an electrocardiographic stress test. If the result is positive or non-diagnostic, coronary cineangiography should be performed, irrespective of the results of esophageal investigations. If the electrocardiographic stress test is negative, coronary investigations can be deferred. Esophageal investigations can account for the symptoms in about half of such cases.
- Published
- 1986
- Full Text
- View/download PDF
17. Pericardial Effusion Mimicking Left Atrial Thrombus after Coronary Bypass Surgery
- Author
-
Carla Giustetto, Bruna Forni, Giuseppina Ferrero, Conte Mr, Ottino Gm, and Giuseppe Steffenino
- Subjects
Male ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Heart Diseases ,Critical Care and Intensive Care Medicine ,Pericardial effusion ,Pericardial Effusion ,Diagnosis, Differential ,Coronary artery bypass surgery ,Internal medicine ,medicine ,Humans ,Pericardium ,Heart Atria ,Derivation ,Angiocardiography ,Coronary Artery Bypass ,medicine.diagnostic_test ,business.industry ,Thrombosis ,Middle Aged ,medicine.disease ,Surgery ,Radiography ,medicine.anatomical_structure ,Effusion ,Bypass surgery ,Echocardiography ,cardiovascular system ,Cardiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
This report describes a patient in whom pericardial effusion, two months after coronary bypass surgery, mimicked the presence of a left atrial mass on both echocardiography and cardiac angiography. (Chest 1989; 95:468-69)
- Published
- 1989
- Full Text
- View/download PDF
18. Bedside evaluation of atrioventricular block with narrow QRS complexes: usefulness of carotid sinus massage and atropine administration
- Author
-
Mangiardi L, Antonio Brusca, Patrizia Presbitero, Rodolfo Bonamini, Fiorenzo Gaita, Conte Mr, and Fulvio Orzan
- Subjects
Adult ,Atropine ,Male ,medicine.medical_specialty ,Bundle of His ,Context (language use) ,Electrocardiography ,Narrow qrs ,Block (telecommunications) ,Internal medicine ,Medicine ,Humans ,cardiovascular diseases ,Aged ,Massage ,medicine.diagnostic_test ,business.industry ,Carotid sinus ,Middle Aged ,medicine.disease ,Electrophysiology ,medicine.anatomical_structure ,Carotid Sinus ,Heart Block ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Atrioventricular block ,medicine.drug - Abstract
Second-degree intra-His bundle block is frequently of type I (Wenckebach periods) or 2:1. In this situation, the surface electrocardiogram does not permit distinction between intranodal (atrioventricular [A-V] and subnodal (intra-His) block. This study examined the value of bedside carotid sinus massage and atropine administration in diagnosing the site of block from the standard electrocardiogram in subjects with chronic A-V block and narrow QRS complexes. Fifteen patients had intra-His bundle block and 10 had intranodal block. The combination of two tests correctly located the site of block in 22 subjects, and was noncontributory in 3. Thirteen of the 15 intra-His bundle blocks and 9 of the 10 intranodal blocks were properly identified; in three cases the results were nondiagnostic, but no wrong diagnoses were made. The noninvasive bedside method of carotid sinus massage and the use of atropine permit both the localization and the determination of the type of block in the majority of cases of second degree A-V block and narrow QRS complexes. In a proper clinical context they can obviate the need for invasive electrophysiologic studies.
- Published
- 1982
19. [Amiodarone in the bradycardia-tachycardia syndrome. 2-year follow-up]
- Author
-
Conte, Mr, Gaita, Fiorenzo, Asteggiano, R., Bocchiardo, M., and Rosettani, E.
- Subjects
Adult ,Male ,Tachycardia ,Bradycardia ,Amiodarone ,Humans ,Female ,Syndrome ,Middle Aged ,Aged ,Benzofurans ,Follow-Up Studies ,Sinoatrial Node - Published
- 1982
20. [Anamnestic study of thoracic pain: comparison of angina and gastroesophageal reflux]
- Author
-
Conte, Mr, Magnacca, M., Orzan, F., Gobbi, G., Zara, Gian Paolo, Mioli, P., and Brusca, A.
- Subjects
Adult ,Male ,Pain ,Coronary Disease ,Endoscopy ,Middle Aged ,Thorax ,Angina Pectoris ,Diagnosis, Differential ,Electrocardiography ,Gastroesophageal Reflux ,Humans ,Female ,Medical History Taking ,Radionuclide Imaging ,Aged - Published
- 1982
21. [Angiographic findings in arrhythmogenic dysplasia of the right ventricle]
- Author
-
Conte, Mr, Presbitero, P., Gaita, Fiorenzo, Tanga, M., Massobrio, N., Orzan, F., and Brusca, Antonio
- Subjects
Adult ,Cardiomyopathy, Dilated ,Ebstein Anomaly ,Male ,Angiocardiography ,Humans ,Arrhythmias, Cardiac ,Female ,Middle Aged ,Cardiomyopathies - Abstract
Arrhythmogenic right ventricular dysplasia is characterized by fibrous and adipose replacement of the right ventricular myocardium and recurrent ventricular arrhythmias of left bundle branch block morphologic pattern. Sometimes the diagnosis is difficult because not all the clinical and instrumental findings are present and the separation between arrhythmogenic right ventricular dysplasia and other right ventricular cardiopathies is uncertain. In such cases the angiographic appearance of the right ventricle has been considered the "gold standard". To assess the diagnostic value of right ventricular morphology in identifying arrhythmogenic right ventricular dysplasia, we compared the angiographic findings of 8 patients with arrhythmogenic right ventricular dysplasia, 10 with biventricular dilated cardiomyopathy and 10 with Ebstein's anomaly. The following aspects were considered: deep fissuring of the anterior or inferior wall, outflow tract enlargement, contrast persistence in the right ventricle during the levophase, regional wall motion abnormalities including aneurysmal formations and tricuspid regurgitation. Aneurysmal formations of the right ventricle were found only in arrhythmogenic right ventricular dysplasia whereas the other angiographic findings were common to all the above mentioned diseases. Right ventricular angiography is an important adjunct to the clinical and instrumental diagnosis of arrhythmogenic right ventricular dysplasia, but most of its angiographic features are common to other diseases which cause right ventricular dilatation.
- Published
- 1989
22. Results of total correction of tetralogy of Fallot performed in adults
- Author
-
D. Demarie, Conte Mr, Patrizia Presbitero, Fulvio Orzan, Morea M, Ottino Gm, E. Aruta, M. Disumma, M.T. Spinnler, Alberto Fubini, and M. Villani
- Subjects
Pulmonary and Respiratory Medicine ,Adult ,Male ,medicine.medical_specialty ,Heart disease ,Hemodynamics ,Intracardiac injection ,Radionuclide angiography ,Postoperative Complications ,Internal medicine ,Methods ,Medicine ,Humans ,cardiovascular diseases ,Tetralogy of Fallot ,Aged ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,General surgery ,Incidence (epidemiology) ,Operative mortality ,Palliative Care ,Palliative procedure ,Arrhythmias, Cardiac ,Stroke Volume ,Middle Aged ,medicine.disease ,Surgery ,Evaluation Studies as Topic ,cardiovascular system ,Cardiology ,Quality of Life ,Female ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
Today, total correction of tetralogy of Fallot is rarely performed in adults. In a 10-year period, 40 patients aged 20 to 67 years underwent intracardiac repair in our institution. Twenty-eight of them had had a palliative procedure 11 to 30 years earlier. Preoperatively, 23 patients were in New York Heart Association (NYHA) Functional Class II, 14 were in Class III, and 3 were in Class IV. Operative mortality was 2.5% (1/40). Follow-up ranged from 1 year to 11 years (average, 3 years). One patient died of a noncardiac cause 4 years after operation. Residual cardiac defects were observed in 4 patients. Postoperatively, 30 patients were in NYHA Functional Class I, 8 were in Class II, and 1 was in Class HI. Major ventricular arrhythmias were recorded in 7 (35%) of 20 patients. Radionuclide angiography demonstrated impaired right ventricular function in 8 patients. Left ventricular impairment was present in 2. Total correction of tetralogy of Fallot can be performed safely in adults with low mortality and good functional improvement. The incidence of residual cardiac defects is low. The long-term importance of impaired ventricular function and arrhythmias remains to be ascertained.
- Published
- 1988
23. 2 cases of arrhythmogenic dysplasia of the right ventricle of familial occurrence
- Author
-
Conte, Mr, Marchese, C., Anselmino, M., Cervasel, C., Gaita, Fiorenzo, Rosettani, E., and Brusca, A.
- Subjects
Male ,Adolescent ,Heart Ventricles ,Humans ,Arrhythmias, Cardiac ,Female ,Middle Aged ,Pedigree - Abstract
Cases of familial arrhythmogenic right ventricular dysplasia (ARVD) have been reported by many authors, and a genetic mechanism of transmission has been hypothesized. Both autosomal dominant and autosomal recessive mechanism of inheritance were suggest. We present a father and a daughter affected by arrhythmogenic right ventricular dysplasia, belonging to a family with many cases of sudden death. Both of them presented with an episode of ventricular tachycardia with left bundle branch block. The clinical diagnosis was made according to electrocardiographic, echocardiographic, angionuclear and hemodynamic criteria of ARVD. The familia analysis suggest an autosomal dominant mechanism of transmission.
- Published
- 1987
24. [Inflammatory mechanisms associated with acute coronary syndrome]
- Author
-
Emanuelli G, Montrucchio G, Alloatti G, Orzan F, Conte MR, Pg, Lucchina, Giovanni Camussi, Brusca A, Cl, Battaglia, and Brusca R
- Subjects
Inflammation ,Acute Disease ,Humans ,Coronary Disease ,Myocardial Reperfusion Injury ,Coronary Artery Disease ,Syndrome
25. [Distribution and appropriateness of hospital admissions, resource utilization in the Italian intensive cardiac care units. The BLITZ-3 study]
- Author
-
Lo, Visconti, Scorcu G, Cassin M, Casella G, Chinaglia A, Conte MR, Fradella G, Lucci D, Aldo Pietro Maggioni, Pirelli S, Chiarella F, and Blitz-, Ricercatori Del
26. Images in cardiology. Acute myocardial infarction due to coronary vasospasm and salbutamol abuse.
- Author
-
Ferrua S, Varbella F, Conte MR, Ferrua, S, Varbella, F, and Conte, M R
- Published
- 2009
- Full Text
- View/download PDF
27. The Italian Registry for hypertrophic cardiomyopathy: a nationwide survey
- Author
-
Sandro Betocchi, Roberto Rordorf, Maurizio Porcu, Franco Cecchi, Elisabetta Zachara, Simona Giampaoli, Stefano Nistri, Antonello Gavazzi, Maria Rosa Conte, Gianfranco Sinagra, Gianfranco Carnemolla, Paolo Gruppillo, Claudio Rapezzi, Iacopo Olivotto, Cecchi, F, Olivotto, I, Betocchi, S, Rapezzi, C, Conte, Mr, Sinagra, Gianfranco, Zachara, E, Gavazzi, A, Rordorf, R, Carnemolla, G, Porcu, M, Nistri, S, Gruppillo, P, Giampaoli, S., Cecchi F, Olivotto I, Betocchi S, Rapezzi C, Conte MR, Sinagra G, Zachara E, Gavazzi A, Rordorf R, Carnemolla G, Porcu M, Nistri S, Gruppillo P, Giampaoli S, Betocchi, Sandro, and Sinagra, G
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pediatrics ,Referral ,Heart disease ,business.industry ,Cardiomyopathy ,Hypertrophic cardiomyopathy ,Atrial fibrillation ,Cardiomyopathy, Hypertrophic ,medicine.disease ,Sudden death ,Italy ,Heart failure ,Internal medicine ,Surveys and Questionnaires ,medicine ,Cardiology ,Humans ,Female ,Registries ,Cardiology and Cardiovascular Medicine ,business ,New York Heart Association Class I - Abstract
National registries are advocated as instrumental to the solution of rarity-related problems for patients with hypertrophic cardiomyopathy (HCM), including limited access to advanced treatment options. Thus, an Italian Registry for HCM was created to assess the clinical profile and the level of care nationwide of patients with HCM. METHODS: Cardiology centers over the national territory were recruited to provide clinical data of all patients with HCM ever seen at each institution. The enrollment period was from May 2000 to May 2002. RESULTS: The registry enrolled 1677 patients from 40 institutions. Most (69%) were followed at referral centers, whereas 31% were from community centers with intermediate-low patient flow. Patients diagnosed after routine medical examinations or familial screenings were 39%. Most patients were male (62%), in their fourth to sixth decade of life, and in New York Heart Association class I to II (89%); 24% had resting left ventricular obstruction and 18% had atrial fibrillation. During a 9.7-year average follow-up, cardiovascular mortality was 1%/y, mostly because of heart failure, with no significant change over the last 3 decades; sudden death was less common (0.4%/y). Only 4% of patients received a defibrillator; 14% of the 401 patients with LV outflow obstruction underwent invasive relief of obstruction; and
- Published
- 2005
28. Long-term outcomes of percutaneous coronary interventions with stent implantation in patients <=40 years old.
- Author
-
Meliga E, De Benedictis M, Gagnor A, Belli R, Scrocca I, Lombardi P, Conrotto F, Aranzulla T, Varbella F, and Conte MR
- Published
- 2012
- Full Text
- View/download PDF
29. Ischemic chest pain and global T-wave inversion in women with normal coronary angiograms.
- Author
-
Brscic E, Brusca A, Presbitero P, Orzan F, Conte MR, Rosettani E, Brscic, E, Brusca, A, Presbitero, P, Orzan, F, Conte, M R, and Rosettani, E
- Abstract
Patients presenting with ischemic chest pain and electrocardiographic evidence of global T-wave inversion are most frequently women with intact left ventricular function and no critical stenosis of major coronary vessels. Hence, this syndrome has a good immediate and long-term prognosis. [ABSTRACT FROM AUTHOR]
- Published
- 1997
- Full Text
- View/download PDF
30. Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry
- Author
-
Corrado Tamburino, Innocenzo Scrocca, Piera Capranzano, Maria Rosa Conte, Mauro De Benedictis, Young-Hak Kim, Jean Fajadet, Roxana Mehran, Tarun Chakravarty, Marie Claude Morice, Ottavio Alfieri, Paweł Buszman, Antonio Colombo, Thierry Lefèvre, Jeffrey W. Moses, Andrejs Erglis, Martin B. Leon, Christoph Naber, Yoshinobu Onuma, Emanuele Meliga, Patrick W. Serruys, Sanda Jegere, Azeem Latib, Ronan Margey, Seung-Jung Park, Marta Bande, Alaide Chieffo, Igor F. Palacios, Raj Makkar, Cardiology, Meliga, E, De Benedictis, M, Chieffo, A, Latib, A, Park, Sj, Kim, Yh, Onuma, Y, Capranzano, P, Jegere, S, Makkar, R, Palacios, I, Buszman, P, Bande, M, Chakravarty, T, Mehran, R, Naber, C, Scrocca, I, Margey, R, Leon, M, Moses, J, Fajadet, J, Lefevre, T, Morice, Mc, Erglis, A, Tamburinos, C, Alfieri, Ottavio, Conte, Mr, Serruys, Pw, and Colombo, A.
- Subjects
medicine.medical_specialty ,Percutaneous ,medicine.medical_treatment ,Medizin ,Coronary Artery Disease ,Percutaneous Coronary Intervention ,SDG 3 - Good Health and Well-being ,Internal medicine ,Diabetes mellitus ,medicine ,Diabetes Mellitus ,Humans ,cardiovascular diseases ,Registries ,Coronary Artery Bypass ,business.industry ,Percutaneous coronary intervention ,Drug-Eluting Stents ,medicine.disease ,Surgery ,Stenosis ,medicine.anatomical_structure ,surgical procedures, operative ,Treatment Outcome ,Drug-eluting stent ,Concomitant ,Conventional PCI ,Cardiology ,Cardiology and Cardiovascular Medicine ,business ,Artery - Abstract
textabstractAims: Data regarding the impact on clinical outcomes of PCI with DES implantation vs. CABG to treat unprotected left main coronary artery (ULMCA) disease in diabetic patients are still insufficient. The present study evaluated the short-term and long-term results of percutaneous and surgical revascularisation in diabetic patients with ULMCA disease in a large population. Methods and results: A total of 826 diabetic patients with ULMCA stenosis who received DES (n=520) or underwent CABG (n=306) were selected and analysed from the DELTA registry. In-hospital MACCE was significantly higher in the CABG group, mainly driven by a higher incidence of MI. At four-year follow-up, freedom from death and the composite endpoint of death, MI and cerebrovascular accident (CVA) was similar in the two treatment groups (CABG 87.4%, PCI 82.5%, p=0.124, and CABG 85.4%, PCI 78.9%, p=0.11, respectively). Conversely, freedom from TVR and MACCE was significantly higher in the CABG compared to the PCI group (CABG 95.4%, PCI 79.4%, p
- Published
- 2013
31. A more detailed picture of the interactions between virtual screening-derived hits and the DNA G-quadruplex: NMR, molecular modelling and ITC studies
- Author
-
Luigi Martino, Valeria La Pietra, Sandro Cosconati, Stefano De Tito, Maria R. Conte, Ilaria Lauri, Luciano Mayol, Roberta Trotta, Antonio Randazzo, Luciana Marinelli, Ettore Novellino, Trotta, R., De Tito, S., Lauri, Ilaria, LA PIETRA, Valeria, Marinelli, Luciana, Cosconati, S., Martino, L., Conte, M. R., Mayol, Luciano, Novellino, Ettore, Randazzo, Antonio, Trotta, R, De Tito, S, Lauri, I, La Pietra, V, Marinelli, L, Cosconati, Sandro, Martino, L, Conte, Mr, Mayol, L, Novellino, E, Randazzo, A., AAVV, Trotta, Roberta, DE TITO, Stefano, Martino, Luigi, and M. R., Conte
- Subjects
Virtual screening ,Models, Molecular ,NMR titration ,Magnetic Resonance Spectroscopy ,Stereochemistry ,Drug Evaluation, Preclinical ,Calorimetry ,G-quadruplex ,Biochemistry ,chemistry.chemical_compound ,Nmr titration ,Molecule ,heterocyclic compounds ,Binding site ,Binding Sites ,Chemistry ,Distamycins ,Isothermal titration calorimetry ,General Medicine ,Nuclear magnetic resonance spectroscopy ,G-Quadruplexes ,Crystallography ,Brominated G-quadruplex ,DNA - Abstract
The growing amount of literature about G-quadruplex DNA clearly demonstrates that such a structure is no longer viewed as just a biophysical strangeness but it is instead being considered as an important target for the treatment of various human disorders such as cancers or venous thrombosis. In this scenario, with the aim of finding brand new molecular scaffolds able to interact with the groove of the DNA quadruplex [d(TGGGGT)] 4, we recently performed a successful structure-based virtual screening (VS) campaign. As a result, six molecules were found to be somehow groove binders. Herein, we report the results of novel NMR titration experiments of these VS-derived ligands with modified quadruplexes, namely [d(TGG BrGGT)] 4 and [d(TGGGG BrT)] 4. The novel NMR spectroscopy experiments combined with molecular modelling studies, allow for a more detailed picture of the interaction between each binder and the quadruplex DNA. Noteworthy, isothermal titration calorimetry (ITC) measurements on the above-mentioned compounds revealed that 2, 4, and 6 besides their relatively small dimensions bind the DNA quadruplex [d(TGGGGT)] 4 with higher affinity than distamycin A, to the best of our knowledge, the most potent groove binder identified thus far. © 2011 Elsevier Masson SAS. All rights reserved.
- Published
- 2011
32. Syncope and risk of sudden death in hypertrophic cardiomyopathy
- Author
-
Barry J. Maron, Roberto Badagliacca, Giovanni Quarta, Caterina S. Barillà, Paola Bernabò, N.A. Mark Estes, Fabio Coccolo, Martin S. Maron, Elena Biagini, Sergio Bongioanni, Claudio Rapezzi, Paolo Spirito, Paolo Bruzzi, Camillo Autore, Maria Rosa Conte, Spirito P, Autore C, Rapezzi C, Bernabò P, Badagliacca R, Maron MS, Bongioanni S, Coccolo F, Estes NA, Barillà CS, Biagini E, Quarta G, Conte MR, Bruzzi P, and Maron BJ
- Subjects
Adult ,Male ,medicine.medical_specialty ,Heart disease ,Adolescent ,Cardiomyopathy ,Neurological disorder ,Kaplan-Meier Estimate ,Sudden death ,Syncope ,Young Adult ,Age Distribution ,Risk Factors ,Physiology (medical) ,Internal medicine ,medicine ,Humans ,Aged ,Proportional Hazards Models ,Proportional hazards model ,business.industry ,Hypertrophic cardiomyopathy ,Cardiomyopathy, Hypertrophic ,Middle Aged ,medicine.disease ,Prognosis ,Confidence interval ,Defibrillators, Implantable ,Death, Sudden, Cardiac ,Anesthesia ,Relative risk ,Multivariate Analysis ,Cardiology ,Female ,cardiomyopathy ,hypertrophic ,death ,sudden ,syncope ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
Background— The prognostic significance of syncope has not been investigated systematically in hypertrophic cardiomyopathy, and treatment strategies have been based largely on intuition and experience. Methods and Results— We assessed the relationship between syncope and sudden death in 1511 consecutive patients with hypertrophic cardiomyopathy. Unexplained (n=153) or neurally mediated (n=52) syncope occurred in 205 patients (14%). Over a 5.6±5.2-year follow-up, 74 patients died suddenly. Relative risk of sudden death was 1.78 (95% confidence interval 0.88 to 3.51, P =0.08) in patients with unexplained syncope and 0.91 (95% confidence interval 0.00 to 3.83, P =1.0) in those with neurally mediated syncope compared with patients without syncope. In multivariable analysis, the temporal proximity of unexplained syncope to initial patient evaluation was independently associated with risk of sudden death ( P =0.006). Patients with unexplained syncope within 6 months before the initial evaluation showed a 5-fold increase in risk compared with patients without syncope (adjusted hazard ratio 4.89, 95% confidence interval 2.19 to 10.94), a relationship that was maintained throughout all age groups (5 years before initial evaluation) did not show an increased risk of sudden death (adjusted hazard ratio 0.38, 95% confidence interval 0.05 to 2.74). Conclusions— In the present large cohort of patients with hypertrophic cardiomyopathy, unexplained syncope was a risk factor for sudden death. Patients with syncopal events that occurred in close temporal proximity to the initial evaluation showed a substantially higher risk of sudden death than patients without syncope. Older patients with remote syncopal events did not show an increased risk.
- Published
- 2009
33. INFECTIVE ENDOCARDITIS IN HYPERTROPHIC CARDIOMYOPATHY: PREVALENCE, INCIDENCE AND INDICATIONS FOR ANTIBIOTIC PROPHYLAXIS
- Author
-
Camillo Autore, Gian Paolo Bezante, Sandro Betocchi, Pietro Bellone, Paolo Bruzzi, Maria Rosa Conte, Claudio Rapezzi, Paolo Spirito, Spirito, P., Rapezzi, C., Bellone, P., Betocchi, Sandro, Autore, C., Conte, Mr, Bezante, Gp, and Bruzzi, P.
- Subjects
Adult ,Male ,medicine.medical_specialty ,Cardiomyopathy ,Risk Factors ,Physiology (medical) ,Internal medicine ,medicine ,Prevalence ,Endocarditis ,Humans ,Antibiotic prophylaxis ,Aged ,Retrospective Studies ,business.industry ,Incidence (epidemiology) ,Incidence ,Hypertrophic cardiomyopathy ,Age Factors ,Endocarditis, Bacterial ,Antibiotic Prophylaxis ,Cardiomyopathy, Hypertrophic ,Middle Aged ,medicine.disease ,Italy ,Acute Endocarditis ,Echocardiography ,Infective endocarditis ,Acute Disease ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,Complication ,business - Abstract
Background —The literature on infective endocarditis in hypertrophic cardiomyopathy (HCM) is virtually confined to case reports. Consequently, the risk of endocarditis in HCM remains undefined. Methods and Results —We assessed the occurrence of endocarditis in 810 HCM patients evaluated between 1970 and 1997. Endocarditis was diagnosed in 10 patients, 2 of whom were excluded from analysis of prevalence and incidence because they were referred for acute endocarditis. At first evaluation, echocardiographic features consistent with prior endocarditis were identified in 3 of 808 patients, a prevalence of 3.7 per 1000 patients (95% CI, 0.8 to 11). Of 681 patients who were followed, 5 developed endocarditis, an incidence of 1.4 per 1000 person-years (95% CI, 0.5 to 3.2); outflow obstruction was present in each of these 5 patients and was associated with the risk of endocarditis ( P =0.006). In the 224 obstructive patients, incidence of endocarditis was 3.8 per 1000 person-years (95% CI, 1.6 to 8.9) and probability of endocarditis 4.3% at 10 years. Left atrial size was also associated with the risk of endocarditis ( P =0.007). In patients with both obstruction and atrial dilatation (≥50 mm), incidence of endocarditis increased to 9.2 per 1000 person-years (95% CI, 2.5 to 23.5). Analysis of all 10 patients with endocarditis identified outflow obstruction in each and atrial dilatation in 7. Conclusions —Endocarditis in HCM is virtually confined to patients with outflow obstruction and is more common in those with both obstruction and atrial dilatation. These results indicate that antibiotic prophylaxis is required only in patients with obstructive HCM.
- Published
- 1999
34. The short conserved region-2 of LARP4 interacts with ribosome-associated RACK1 and promotes translation.
- Author
-
Ranjan A, Mattijssen S, Charlly N, Gallardo IC, Pitman LF, Coleman JC, Conte MR, and Maraia RJ
- Subjects
- Humans, Protein Binding, RNA, Messenger metabolism, RNA, Messenger genetics, HEK293 Cells, Mutation, AU Rich Elements genetics, RNA Stability genetics, Conserved Sequence, GTP-Binding Proteins metabolism, GTP-Binding Proteins genetics, Receptors for Activated C Kinase metabolism, Receptors for Activated C Kinase genetics, Protein Biosynthesis, Ribosomes metabolism, Ribosomes genetics, SS-B Antigen, Ribonucleoproteins metabolism, Ribonucleoproteins genetics, Autoantigens metabolism, Autoantigens genetics, Neoplasm Proteins metabolism, Neoplasm Proteins genetics
- Abstract
LARP4 interacts with poly(A)-binding protein (PABP) to protect messenger RNAs (mRNAs) from deadenylation and decay, and recent data indicate it can direct the translation of functionally related mRNA subsets. LARP4 was known to bind RACK1, a ribosome-associated protein, although the specific regions involved and relevance had been undetermined. Here, through a combination of in-cell and in vitro methodologies, we identified positions 615-625 in conserved region-2 (CR2) of LARP4 (and 646-656 in LARP4B) as directly binding RACK1. Consistent with these results, AlphaFold2-Multimer predicted high-confidence interaction of CR2 with RACK1 propellers 5 and 6. CR2 mutations strongly decreased LARP4 association with cellular RACK1 and ribosomes by multiple assays, whereas PABP association was less affected, consistent with independent interactions. The CR2 mutations decreased LARP4's ability to stabilize a β-globin mRNA reporter containing an AU-rich element (ARE) to higher degree than β-globin and GFP (green fluorescent protein) mRNAs lacking the ARE. We show LARP4 robustly increases translation of β-glo-ARE mRNA, whereas the LARP4 CR2 mutant is impaired. Analysis of nanoLuc-ARE mRNA for production of luciferase activity confirmed LARP4 promotes translation efficiency, while CR2 mutations are disabling. Thus, LARP4 CR2-mediated interaction with RACK1 can promote translational efficiency of some mRNAs., (Published by Oxford University Press on behalf of Nucleic Acids Research 2025.)
- Published
- 2025
- Full Text
- View/download PDF
35. The short conserved region-2 of LARP4 interacts with ribosome-associated RACK1 and promotes translation.
- Author
-
Ranjan A, Mattijssen S, Charlly N, Gallardo IC, Pitman LF, Coleman JC, Conte MR, and Maraia RJ
- Abstract
LARP4 interacts with poly(A)-binding protein (PABP) to protect mRNAs from deadenylation and decay, and recent data indicate it can direct the translation of functionally related mRNA subsets. LARP4 was known to bind RACK1, a ribosome-associated protein, although the specific regions involved, and relevance had been undetermined. Here, yeast two-hybrid domain mapping followed by other methods identified positions 615-625 in conserved region-2 (CR2) of LARP4 (and LARP4B) as directly binding RACK1 region 200-317. Consistent with these results, AlphaFold2-multimer predicted high confidence interaction of CR2 with RACK1 propellers 5-6. CR2 mutations strongly decreased LARP4 association with cellular RACK1 and ribosomes by multiple assays, whereas less effect was observed for PABP association, consistent with independent interactions. CR2 mutations decreased LARP4 ability to optimally stabilize a β-globin mRNA reporter containing an AU-rich element (ARE) more significantly than a β-globin and other reporters lacking this element. While polysome profiles indicate the β-glo-ARE mRNA is inefficiently translated, consistent with published data, we show that LARP4 increases its translation whereas the LARP4-CR2 mutant is impaired. Analysis of nanoLuc-ARE mRNA for production of luciferase activity confirmed LARP4 promotes translation efficiency while CR2 mutations are disabling. Thus, LARP4 CR2-mediated interaction with RACK1 can promote translational efficiency of some mRNAs., Competing Interests: COMPETING INTERESTS. The authors declare no competing interests.
- Published
- 2024
- Full Text
- View/download PDF
36. The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis.
- Author
-
Coleman JC, Tattersall L, Yianni V, Knight L, Yu H, Hallett SR, Johnson P, Caetano AJ, Cosstick C, Ridley AJ, Gartland A, Conte MR, and Grigoriadis AE
- Abstract
RNA-binding proteins (RBPs) are emerging as important regulators of cancer pathogenesis. We reveal that the RBPs LARP4A and LARP4B are differentially overexpressed in osteosarcoma and osteosarcoma lung metastases, as well as in prostate cancer. Depletion of LARP4A and LARP4B reduced tumor growth and metastatic spread in xenografts, as well as inhibiting cell proliferation, motility, and migration. Transcriptomic profiling and high-content multiparametric analyses unveiled a central role for LARP4B, but not LARP4A, in regulating cell cycle progression in osteosarcoma and prostate cancer cells, potentially through modulating key cell cycle proteins such as Cyclins B1 and E2, Aurora B, and E2F1. This first systematic comparison between LARP4A and LARP4B assigns new pro-tumorigenic functions to LARP4A and LARP4B in bone and prostate cancer, highlighting their similarities while also indicating distinct functional differences. Uncovering clear biological roles for these paralogous proteins provides new avenues for identifying tissue-specific targets and potential druggable intervention., Competing Interests: The authors declare that they have no competing interests., (© 2024.)
- Published
- 2024
- Full Text
- View/download PDF
37. The metabolic effects of intermittent versus continuous feeding in critically ill patients.
- Author
-
Wilkinson D, Gallagher IJ, McNelly A, Bear DE, Hart N, Montgomery HE, Le Guennec A, Conte MR, Francis T, Harridge SDR, Atherton PJ, and Puthucheary ZA
- Subjects
- Humans, Alanine, Carnitine, Ketones, Critical Illness, Amino Acids
- Abstract
Intermittent (or bolus) feeding regimens in critically ill patients have been of increasing interest to clinicians and scientists. Changes in amino acid, fat and carbohydrate metabolites over time might yet deliver other benefits (e.g. modulation of the circadian rhythm and sleep, and impacts on ghrelin secretion, insulin resistance and autophagy). We set out to characterise these changes in metabolite concentration. The Intermittent versus Continuous Feeding in Critically Ill paitents study (NCT02358512) was an eight-centre single-blinded randomised controlled trial. Patients were randomised to received a continuous (control arm) or intermittent (6x/day, intervention arm) enteral feeding regimen. Blood samples were taken on trial days 1, 7 and 10 immediately before and 30 min after intermittent feeds, and at equivalent timepoints in the control arm. A pre-planned targeted metabolomic analysis was performend using Nuclear Resonance Spectroscopy. Five hundred and ninety four samples were analysed from 75 patients. A total of 24 amino acid-, 19 lipid based-, and 44 small molecule metabolite features. Across the main two axes of variation (40-60% and 6-8% of variance), no broad patterns distinguished between intermittent or continuous feeding arms, across intra-day sampling times or over the 10 days from initial ICU admission. Logfold decreases in abundance were seen in metabolites related to amino acids (Glutamine - 0.682; Alanine - 0.594), ketone body metabolism (Acetone - 0.64; 3-Hydroxybutyric Acid - 0.632; Acetonacetic Acid - 0.586), fatty acid (carnitine - 0.509) and carbohydrate metabolism ( Maltose - 0.510; Citric Acid - 0.485). 2-3 Butanediol, a by-product of sugar-fermenting microbial metabolism also decreased (- 0.489). No correlation was seen with change in quadriceps muscle mass for any of the 20 metabolites varying with time (all p > 0.05). Increasing severity of organ failure was related to increasing ketone body metabolism (3 Hydroxybutyric Acid-1 and - 3; p = 0.056 and p = 0.014), carnitine deficiency (p = 0.002) and alanine abundancy (p - 0.005). A 6-times a day intermittent feeding regimen did not alter metabolite patterns across time compared to continuous feeding in critically ill patients, either within a 24 h period or across 10 days of intervention. Future research on intermittent feeding regimens should focus on clinical process benefits, or extended gut rest and fasting., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
38. LARP4A and LARP4B in cancer: The new kids on the block.
- Author
-
Coleman JC, Hallett SR, Grigoriadis AE, and Conte MR
- Subjects
- Humans, Autoantigens genetics, RNA-Binding Proteins genetics, Genes, Tumor Suppressor, Ribonucleoproteins genetics, Ribonucleoproteins metabolism, Neoplasms genetics
- Abstract
Recent developments have mounted a stunning body of evidence underlying the importance of RNA binding proteins (RBPs) in cancer research. In this minireview we focus on LARP4A and LARP4B, two paralogs belonging to the superfamily of La-related proteins, and provide a critical overview of current research, including their roles in cancer pathogenesis and cell proliferation, migration, cell cycle and apoptosis. We highlight current controversies surrounding LARP4A and LARP4B and conclude that their complex roles in tumorigenesis are cell-, tissue- and context-dependent, warning that caution must be exercised before categorising either protein as an oncoprotein or tumour-suppressor. We also reveal that LARP4A and LARP4B have often been confused with one another, adding uncertainty in delineating their functions. We suggest that further functional and mechanistic studies of LARP4 proteins present significant challenges for future investigations to recognise the vital contributions of these RBPs in cancer research., Competing Interests: Declaration of Competing Interest The authors declare there are no conflicts of interest to disclose., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
39. AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin-dependent cell migration.
- Author
-
Crosas-Molist E, Graziani V, Maiques O, Pandya P, Monger J, Samain R, George SL, Malik S, Salise J, Morales V, Le Guennec A, Atkinson RA, Marti RM, Matias-Guiu X, Charras G, Conte MR, Elosegui-Artola A, Holt M, and Sanz-Moreno V
- Subjects
- Humans, Adenosine Triphosphate metabolism, Cell Adhesion, Cell Movement physiology, Myosin Type II metabolism, Oxidative Phosphorylation, Phosphorylation, AMP-Activated Protein Kinases metabolism, Mitochondrial Dynamics, Neoplasms
- Abstract
Cell migration is crucial for cancer dissemination. We find that AMP-activated protein kinase (AMPK) controls cell migration by acting as an adhesion sensing molecular hub. In 3-dimensional matrices, fast-migrating amoeboid cancer cells exert low adhesion/low traction linked to low ATP/AMP, leading to AMPK activation. In turn, AMPK plays a dual role controlling mitochondrial dynamics and cytoskeletal remodelling. High AMPK activity in low adhering migratory cells, induces mitochondrial fission, resulting in lower oxidative phosphorylation and lower mitochondrial ATP. Concurrently, AMPK inactivates Myosin Phosphatase, increasing Myosin II-dependent amoeboid migration. Reducing adhesion or mitochondrial fusion or activating AMPK induces efficient rounded-amoeboid migration. AMPK inhibition suppresses metastatic potential of amoeboid cancer cells in vivo, while a mitochondrial/AMPK-driven switch is observed in regions of human tumours where amoeboid cells are disseminating. We unveil how mitochondrial dynamics control cell migration and suggest that AMPK is a mechano-metabolic sensor linking energetics and the cytoskeleton., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
40. Metabolic rewiring in MYC-driven medulloblastoma by BET-bromodomain inhibition.
- Author
-
Graziani V, Garcia AR, Alcolado LS, Le Guennec A, Henriksson MA, and Conte MR
- Subjects
- Child, Humans, Nuclear Proteins metabolism, Proto-Oncogene Proteins c-myc metabolism, Transcription Factors metabolism, Cell Line, Tumor, Medulloblastoma pathology, Cerebellar Neoplasms pathology
- Abstract
Medulloblastoma (MB) is the most common malignant brain tumour in children. High-risk MB patients harbouring MYC amplification or overexpression exhibit a very poor prognosis. Aberrant activation of MYC markedly reprograms cell metabolism to sustain tumorigenesis, yet how metabolism is dysregulated in MYC-driven MB is not well understood. Growing evidence unveiled the potential of BET-bromodomain inhibitors (BETis) as next generation agents for treating MYC-driven MB, but whether and how BETis may affect tumour cell metabolism to exert their anticancer activities remains unknown. In this study, we explore the metabolic features characterising MYC-driven MB and examine how these are altered by BET-bromodomain inhibition. To this end, we employed an NMR-based metabolomics approach applied to the MYC-driven MB D283 and D458 cell lines before and after the treatment with the BETi OTX-015. We found that OTX-015 triggers a metabolic shift in both cell lines resulting in increased levels of myo-inositol, glycerophosphocholine, UDP-N-acetylglucosamine, glycine, serine, pantothenate and phosphocholine. Moreover, we show that OTX-015 alters ascorbate and aldarate metabolism, inositol phosphate metabolism, phosphatidylinositol signalling system, glycerophospholipid metabolism, ether lipid metabolism, aminoacyl-tRNA biosynthesis, and glycine, serine and threonine metabolism pathways in both cell lines. These insights provide a metabolic characterisation of MYC-driven childhood MB cell lines, which could pave the way for the discovery of novel druggable pathways. Importantly, these findings will also contribute to understand the downstream effects of BETis on MYC-driven MB, potentially aiding the development of new therapeutic strategies to combat medulloblastoma., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
41. Allosteric Regulation of the Soluble Epoxide Hydrolase by Nitro Fatty Acids: a Combined Experimental and Computational Approach.
- Author
-
Qiu Q, Abis G, Mattingly-Peck F, Lynham S, Fraternali F, and Conte MR
- Subjects
- Allosteric Regulation drug effects, Cysteine metabolism, Humans, Epoxide Hydrolases antagonists & inhibitors, Epoxide Hydrolases chemistry, Epoxide Hydrolases metabolism, Linoleic Acids chemistry, Linoleic Acids pharmacology, Nitro Compounds chemistry, Nitro Compounds pharmacology
- Abstract
The human soluble epoxide hydrolase (hsEH) is a key regulator of epoxy fatty acid (EpFA) metabolism. Inhibition of sEH can maintain endogenous levels of beneficial EpFAs and reduce the levels of their corresponding diol products, thus ameliorating a variety of pathological conditions including cardiovascular, central nervous system and metabolic diseases. The quest for orthosteric drugs that bind directly to the catalytic crevice of hsEH has been prolonged and sustained over the past decades, but the disappointing outcome of clinical trials to date warrants alternative pharmacological approaches. Previously, we have shown that hsEH can be allosterically inhibited by the endogenous electrophilic lipid 15-deoxy-Δ
12,14 -Prostaglandin-J2 , via covalent adduction to two cysteines, C423 and C522. In this study, we explore the properties and behaviour of three electrophilic lipids belonging to the class of the nitro fatty acids, namely 9- and 10-nitrooleate and 10-nitrolinoleate. Biochemical and biophysical investigations revealed that, in addition to C423 and C522, nitro fatty acids can covalently bind to additional nucleophilic residues in hsEH C-terminal domain (CTD), two of which predicted in this study to be latent allosteric sites. Systematic mapping of the protein mutational space and evaluation of possible propagation pathways delineated selected residues, both in the allosteric patches and in other regions of the enzyme, envisaged to play a role in allosteric signalling. The responses elicited by the ligands on the covalent adduction sites supports future fragment-based design studies of new allosteric effectors for hsEH with increased efficacy and selectivity., Competing Interests: Declaration of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
42. Structural basis of dimerization and nucleic acid binding of human DBHS proteins NONO and PSPC1.
- Author
-
Knott GJ, Chong YS, Passon DM, Liang XH, Deplazes E, Conte MR, Marshall AC, Lee M, Fox AH, and Bond CS
- Subjects
- Dimerization, Humans, Models, Molecular, Protein Conformation, RNA Splicing, DNA-Binding Proteins metabolism, RNA metabolism, RNA-Binding Proteins metabolism
- Abstract
The Drosophila behaviour/human splicing (DBHS) proteins are a family of RNA/DNA binding cofactors liable for a range of cellular processes. DBHS proteins include the non-POU domain-containing octamer-binding protein (NONO) and paraspeckle protein component 1 (PSPC1), proteins capable of forming combinatorial dimers. Here, we describe the crystal structures of the human NONO and PSPC1 homodimers, representing uncharacterized DBHS dimerization states. The structures reveal a set of conserved contacts and structural plasticity within the dimerization interface that provide a rationale for dimer selectivity between DBHS paralogues. In addition, solution X-ray scattering and accompanying biochemical experiments describe a mechanism of cooperative RNA recognition by the NONO homodimer. Nucleic acid binding is reliant on RRM1, and appears to be affected by the orientation of RRM1, influenced by a newly identified 'β-clasp' structure. Our structures shed light on the molecular determinants for DBHS homo- and heterodimerization and provide a basis for understanding how DBHS proteins cooperatively recognize a broad spectrum of RNA targets., (© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2022
- Full Text
- View/download PDF
43. A thiol redox sensor in soluble epoxide hydrolase enables oxidative activation by intra-protein disulfide bond formation.
- Author
-
Charles RL, Abis G, Fernandez BF, Guttzeit S, Buccafusca R, Conte MR, and Eaton P
- Subjects
- Animals, Disulfides, Hydrogen Peroxide, Mice, Oxidation-Reduction, Oxidative Stress, Epoxide Hydrolases genetics, Epoxide Hydrolases metabolism, Sulfhydryl Compounds
- Abstract
Soluble epoxide hydrolase (sEH), an enzyme that broadly regulates the cardiovascular system, hydrolyses epoxyeicosatrienoic acids (EETs) to their corresponding dihydroxyeicosatrienoic acids (DHETs). We previously showed that endogenous lipid electrophiles adduct within the catalytic domain, inhibiting sEH to lower blood pressure in angiotensin II-induced hypertensive mice. As angiotensin II increases vascular H
2 O2 , we explored sEH redox regulation by this oxidant and how this integrates with inhibition by lipid electrophiles to regulate vasotone. Kinetics analyses revealed that H2 O2 not only increased the specific activity of sEH but increased its affinity for substrate and increased its catalytic efficiency. This oxidative activation was mediated by formation of an intra-disulfide bond between C262 and C264, as determined by mass spectrometry and substantiated by biotin-phenylarsinate and thioredoxin-trapping mutant assays. C262S/264S sEH mutants were resistant to peroxide-induced activation, corroborating the disulfide-activation mechanism. The physiological impact of sEH redox state was determined in isolated arteries and the effect of the pro-oxidant vasopressor angiotensin II on arterial sEH redox state and vasodilatory EETs indexed in mice. Angiotensin II induced the activating intra-disulfide in sEH, causing a decrease in plasma EET/DHET ratios that is consistent with the pressor response to this hormone. Although sEH C262-C264 disulfide formation enhances hydrolysis of vasodilatory EETs, this modification also sensitized sEH to inhibition by lipid electrophiles. This explains why angiotensin II decreases EETs and increases blood pressure, but when lipid electrophiles are also present, that EETs are increased and blood pressure lowered., (Copyright © 2021 Queen Mary University of London. Published by Elsevier B.V. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF
44. LARP6C orchestrates posttranscriptional reprogramming of gene expression during hydration to promote pollen tube guidance.
- Author
-
Billey E, Hafidh S, Cruz-Gallardo I, Litholdo CG, Jean V, Carpentier MC, Picart C, Kumar V, Kulichova K, Maréchal E, Honys D, Conte MR, Deragon JM, and Bousquet-Antonelli C
- Subjects
- 5' Untranslated Regions, Arabidopsis cytology, Arabidopsis growth & development, Binding Sites, Cytoplasmic Granules genetics, Cytoplasmic Granules metabolism, Gene Expression Regulation, Plant, Lipids biosynthesis, Lipids genetics, Plants, Genetically Modified, Pollen Tube cytology, Pollen Tube growth & development, Protein Binding, RNA, Messenger genetics, RNA, Messenger metabolism, RNA, Plant metabolism, Nicotiana genetics, Arabidopsis genetics, Arabidopsis Proteins genetics, Arabidopsis Proteins metabolism, Pollen Tube genetics, RNA-Binding Proteins genetics, RNA-Binding Proteins metabolism
- Abstract
Increasing evidence suggests that posttranscriptional regulation is a key player in the transition between mature pollen and the progamic phase (from pollination to fertilization). Nonetheless, the actors in this messenger RNA (mRNA)-based gene expression reprogramming are poorly understood. We demonstrate that the evolutionarily conserved RNA-binding protein LARP6C is necessary for the transition from dry pollen to pollen tubes and the guided growth of pollen tubes towards the ovule in Arabidopsis thaliana. In dry pollen, LARP6C binds to transcripts encoding proteins that function in lipid synthesis and homeostasis, vesicular trafficking, and polarized cell growth. LARP6C also forms cytoplasmic granules that contain the poly(A) binding protein and possibly represent storage sites for translationally silent mRNAs. In pollen tubes, the loss of LARP6C negatively affects the quantities and distribution of storage lipids, as well as vesicular trafficking. In Nicotiana benthamiana leaf cells and in planta, analysis of reporter mRNAs designed from the LARP6C target MGD2 provided evidence that LARP6C can shift from a repressor to an activator of translation when the pollen grain enters the progamic phase. We propose that LARP6C orchestrates the timely posttranscriptional regulation of a subset of mRNAs in pollen during the transition from the quiescent to active state and along the progamic phase to promote male fertilization in plants., (© American Society of Plant Biologists 2021. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
45. Clinical Course of Pregnancy and Long-Term Follow-Up After Delivery in Hypertrophic Cardiomyopathy.
- Author
-
Musumeci MB, Spirito P, Conte MR, Lillo R, Devoto E, Francia P, Russo D, Volpe M, Boni L, and Autore C
- Subjects
- Adult, Cardiomyopathy, Hypertrophic diagnosis, Cohort Studies, Female, Follow-Up Studies, Humans, Pregnancy, Pregnancy Complications, Cardiovascular diagnosis, Cardiomyopathy, Hypertrophic epidemiology, Cardiomyopathy, Hypertrophic physiopathology, Disease Progression, Pregnancy Complications, Cardiovascular epidemiology, Pregnancy Complications, Cardiovascular physiopathology, Pregnancy Outcome epidemiology
- Published
- 2021
- Full Text
- View/download PDF
46. Structural dynamics in the La-module of La-related proteins.
- Author
-
Lizarrondo J, Dock-Bregeon AC, Martino L, and Conte MR
- Subjects
- Binding Sites, Crystallography, X-Ray, Humans, Protein Binding, RNA chemistry, RNA metabolism, RNA-Binding Proteins genetics, RNA-Binding Proteins metabolism, Recombinant Proteins, Ribonucleoproteins genetics, Ribonucleoproteins metabolism, Spectrum Analysis, Structure-Activity Relationship, Models, Molecular, Protein Conformation, Protein Interaction Domains and Motifs, RNA-Binding Proteins chemistry, Ribonucleoproteins chemistry
- Abstract
The La-related proteins (LaRPs) are a superfamily of eukaryotic RNA-binding proteins with important and varied roles. To understand LaRP functions it is essential to unravel the divergent features responsible for their RNA target selectivity, which underlie their distinct identities and cellular roles. LaRPs are built on a common structural module called the 'La-module' that acts as a main locus for RNA recognition. The La-module is comprised of two tethered domains whose relative structural and dynamic interplay has been proposed to regulate RNA-target selection, albeit the mechanistic underpinning of this recognition remains to be elucidated. A main unsolved conundrum is how conserved La-modules across LaRPs are able to bind to extremely diverse RNA ligands.In this work, we employed Small Angle X-ray Scattering (SAXS) to investigate several human LaRP La-modules in the absence and, where applicable, in the presence of their RNA target, with the aim to explore the structural dynamics of their RNA recognition and provide information on the architectural landscape accessible to these proteins. Integration of these SAXS experiments with prior X-ray crystallography and NMR data suggests that RNA binding is generally accompanied by a compaction and loss of flexibility of the La-module. Nonetheless, the La-modules appear to experience a considerably different degree of inherent flexibility in their apo state. Furthermore, although they all exist in discrete subsets of accessible populations in equilibrium, these vary from LaRP to LaRP and can be either extended or compact. We propose that these divergent features may be critical for RNA substrate discrimination.
- Published
- 2021
- Full Text
- View/download PDF
47. The La-related proteins: structures and interactions of a versatile superfamily of RNA-binding proteins.
- Author
-
Dock-Bregeon AC, Lewis KA, and Conte MR
- Subjects
- Amino Acid Sequence, Binding Sites, Humans, Multigene Family, Protein Binding, Protein Conformation, Protein Interaction Domains and Motifs, RNA chemistry, RNA metabolism, RNA Cleavage, RNA-Binding Proteins genetics, Ribonucleoproteins genetics, Ribonucleoside Diphosphate Reductase chemistry, Ribonucleoside Diphosphate Reductase metabolism, Structure-Activity Relationship, Substrate Specificity, RNA-Binding Proteins chemistry, RNA-Binding Proteins metabolism, Ribonucleoproteins chemistry, Ribonucleoproteins metabolism
- Abstract
The La-related proteins (LaRPs) are an ancient superfamily of RNA-binding proteins orchestrating the major fates of RNA, from processing and maturation to regulation of mRNA translation. LaRPs are instrumental in modulating complex assemblies where the RNA is bound, folded, processed, escorted and presented to the functional effectors often through recruitment of protein partners. This intricate web of protein-RNA and protein-protein interactions is enabled by the modular nature of the LaRPs, comprising several structured domains connected by flexible linkers, and other sequences lacking recognizable folded motifs. Recent structures, together with biochemical and biophysical studies, have provided insights into how each LaRP family has evolved unique mechanisms of RNA recognition, not only through the conserved RNA-binding unit, the La-module, but also mediated by other family-specific motifs. Furthermore, in a series of unexpected twists and turns, they have revealed that the dynamic and conformational interplay of multi-structured domains and disordered regions operate in unison to achieve RNA substrate discrimination. This review proposes a perspective of our current knowledge of the structure-function relationship of the LaRP superfamily.
- Published
- 2021
- Full Text
- View/download PDF
48. Mining the PDB for Tractable Cases Where X-ray Crystallography Combined with Fragment Screens Can Be Used to Systematically Design Protein-Protein Inhibitors: Two Test Cases Illustrated by IL1β-IL1R and p38α-TAB1 Complexes.
- Author
-
Nichols C, Ng J, Keshu A, Kelly G, Conte MR, Marber MS, Fraternali F, and De Nicola GF
- Subjects
- Adamantane analogs & derivatives, Adamantane metabolism, Adaptor Proteins, Signal Transducing chemistry, Animals, Binding Sites, Crystallography, X-Ray, Databases, Protein, Humans, Interleukin-1beta chemistry, Mitogen-Activated Protein Kinase 14 chemistry, Protein Binding drug effects, Receptors, Interleukin-1 chemistry, Sulfonamides chemistry, Sulfonamides metabolism, Yeasts chemistry, Adaptor Proteins, Signal Transducing metabolism, Interleukin-1beta metabolism, Mitogen-Activated Protein Kinase 14 metabolism, Protein Multimerization drug effects, Receptors, Interleukin-1 metabolism
- Abstract
Nowadays, it is possible to combine X-ray crystallography and fragment screening in a medium throughput fashion to chemically probe the surfaces used by proteins to interact and use the outcome of the screens to systematically design protein-protein inhibitors. To prove it, we first performed a bioinformatics analysis of the Protein Data Bank protein complexes, which revealed over 400 cases where the crystal lattice of the target in the free form is such that large portions of the interacting surfaces are free from lattice contacts and therefore accessible to fragments during soaks. Among the tractable complexes identified, we then performed single fragment crystal screens on two particular interesting cases: the Il1β-ILR and p38α-TAB1 complexes. The result of the screens showed that fragments tend to bind in clusters, highlighting the small-molecule hotspots on the surface of the target protein. In most of the cases, the hotspots overlapped with the binding sites of the interacting proteins.
- Published
- 2020
- Full Text
- View/download PDF
49. Maternal Larp6 controls oocyte development, chorion formation and elevation.
- Author
-
Hau HTA, Ogundele O, Hibbert AH, Monfries CAL, Exelby K, Wood NJ, Nevarez-Mejia J, Carbajal MA, Fleck RA, Dermit M, Mardakheh FK, Williams-Ward VC, Pipalia TG, Conte MR, and Hughes SM
- Subjects
- Animals, Cell Movement, Cell Proliferation, Collagen physiology, Egg Proteins physiology, Female, Gene Editing, Gene Expression Profiling, Gene Expression Regulation, Developmental, Genome, Genotype, Heterozygote, Homozygote, Lectins physiology, Male, Mutation, Oocytes cytology, Oogenesis physiology, Phenotype, Zebrafish, Zona Pellucida physiology, SS-B Antigen, Autoantigens genetics, Autoantigens physiology, Chorion physiology, Oocytes physiology, Ribonucleoproteins genetics, Ribonucleoproteins physiology
- Abstract
La-related protein 6 (Larp6) is a conserved RNA-binding protein found across eukaryotes that has been suggested to regulate collagen biogenesis, muscle development, ciliogenesis, and various aspects of cell proliferation and migration. Zebrafish have two Larp6 family genes: larp6a and larp6b Viable and fertile single and double homozygous larp6a and larp6b zygotic mutants revealed no defects in muscle structure, and were indistinguishable from heterozygous or wild-type siblings. However, larp6a mutant females produced eggs with chorions that failed to elevate fully and were fragile. Eggs from larp6b single mutant females showed minor chorion defects, but chorions from eggs laid by larp6a;larp6b double mutant females were more defective than those from larp6a single mutants. Electron microscopy revealed defective chorionogenesis during oocyte development. Despite this, maternal zygotic single and double mutants were viable and fertile. Mass spectrometry analysis provided a description of chorion protein composition and revealed significant reductions in a subset of zona pellucida and lectin-type proteins between wild-type and mutant chorions that paralleled the severity of the phenotype. We conclude that Larp6 proteins are required for normal oocyte development, chorion formation and egg activation., Competing Interests: Competing interestsThe authors declare no competing or financial interests., (© 2020. Published by The Company of Biologists Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
50. Isothermal Titration Calorimetry Enables Rapid Characterization of Enzyme Kinetics and Inhibition for the Human Soluble Epoxide Hydrolase.
- Author
-
Abis G, Pacheco-Gómez R, Bui TTT, and Conte MR
- Subjects
- Adamantane analogs & derivatives, Adamantane chemistry, Biocatalysis, Epoxide Hydrolases antagonists & inhibitors, Epoxide Hydrolases metabolism, Epoxy Compounds metabolism, Fatty Acids metabolism, Flow Injection Analysis methods, Humans, Hydrolysis, Kinetics, Lauric Acids chemistry, Lipid Metabolism, Recombinant Proteins chemistry, Recombinant Proteins metabolism, Solutions, Substrate Specificity, Calorimetry methods, Enzyme Assays, Epoxide Hydrolases chemistry, Epoxy Compounds chemistry, Fatty Acids chemistry
- Abstract
Isothermal titration calorimetry (ITC) is conventionally used to acquire thermodynamic data for biological interactions. In recent years, ITC has emerged as a powerful tool to characterize enzyme kinetics. In this study, we have adapted a single-injection method (SIM) to study the kinetics of human soluble epoxide hydrolase (hsEH), an enzyme involved in cardiovascular homeostasis, hypertension, nociception, and insulin sensitivity through the metabolism of epoxy-fatty acids (EpFAs). In the SIM method, the rate of reaction is determined by monitoring the thermal power, while the substrate is being depleted, overcoming the need for synthetic substrates and reducing postreaction processing. Our results show that ITC enables the detailed, rapid, and reproducible characterization of the hsEH-mediated hydrolysis of several natural EpFA substrates. Furthermore, we have applied a variant of the single-injection ITC method for the detailed description of enzyme inhibition, proving the power of this approach in the rapid screening and discovery of new hsEH inhibitors using the enzyme's physiological substrates. The methods described herein will enable further studies on EpFAs' metabolism and biology, as well as drug discovery investigations to identify and characterize hsEH inhibitors. This also promises to provide a general approach for the characterization of lipid catalysis, given the challenges that lipid metabolism studies pose to traditional spectroscopic techniques.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.